Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Human leukocyte antigen (HLA) typing by DNA sequencing.

Literature DB >> 23775737

Human leukocyte antigen (HLA) typing by DNA sequencing.

Ana Lazaro¹, Bin Tu, Ruyan Yang, Yi Xiao, Kanthi Kariyawasam, Jennifer Ng, Carolyn Katovich Hurley.

Abstract

DNA sequencing is a powerful technique for identifying allelic variation within the human leukocyte antigen (HLA) genes. Sequencing is usually focused on the most polymorphic exons of the class I (HLA-A, -B, -C) and class II (HLA-DR, -DQ, and -DP) genes. These exons encode the antigen recognition site, the region of the HLA molecule that binds peptides and interacts with the T cell receptor for antigen and natural killer cell immunoglobulin-like receptors (KIR). Sanger sequencing of amplified DNA from each HLA gene from a preparation containing one or two alleles yields a sequence that is used to identify the alleles by comparison with a reference database.

Entities: Gene Species

Mesh：

Substances：

Year: 2013 PMID： 23775737 DOI： 10.1007/978-1-62703-493-7_9

Source DB: PubMed Journal: Methods Mol Biol ISSN： 1064-3745

Keyword Cloud
Cited

13 in total

1. HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial.

Authors: Heather A Prentice; Philip K Ehrenberg; Karen M Baldwin; Aviva Geretz; Charla Andrews; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; Robert J O'Connell; Merlin L Robb; Jerome H Kim; Nelson L Michael; Rasmi Thomas
Journal: Immunogenetics Date: 2014-03-29 Impact factor: 2.846

Review 2. Therapeutic cancer vaccines.

Authors: Mansi Saxena; Sjoerd H van der Burg; Cornelis J M Melief; Nina Bhardwaj
Journal: Nat Rev Cancer Date: 2021-04-27 Impact factor: 60.716

3. HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotype.

Authors: Shuying S Li; Andrew Hickey; Shida Shangguan; Philip K Ehrenberg; Aviva Geretz; Lauryn Butler; Gautam Kundu; Richard Apps; Matthew Creegan; Robert J Clifford; Suteeraporn Pinyakorn; Leigh Anne Eller; Pikunchai Luechai; Peter B Gilbert; Timothy H Holtz; Anupong Chitwarakorn; Carlo Sacdalan; Eugène Kroon; Nittaya Phanuphak; Mark de Souza; Jintanat Ananworanich; Robert J O'Connell; Merlin L Robb; Nelson L Michael; Sandhya Vasan; Rasmi Thomas
Journal: Cell Host Microbe Date: 2022-07-15 Impact factor: 31.316

4. Validation of Single Nucleotide Variant Assays for Human Leukocyte Antigen Haplotypes HLA-B15:02* and HLA-A31:01* Across Diverse Ancestral Backgrounds.

Authors: Amanda Buchner; Xiuying Hu; Katherine J Aitchison
Journal: Front Pharmacol Date: 2021-07-26 Impact factor: 5.988

5. HLA Haplotype Validator for quality assessments of HLA typing.

Authors: Kazutoyo Osoegawa; Steven J Mack; Julia Udell; David A Noonan; Steven Ozanne; Elizabeth Trachtenberg; Matthew Prestegaard
Journal: Hum Immunol Date: 2015-11-10 Impact factor: 2.850

Review 6. Quality control project of NGS HLA genotyping for the 17th International HLA and Immunogenetics Workshop.

Authors: Kazutoyo Osoegawa; Tamara A Vayntrub; Sabine Wenda; Dianne De Santis; Konstantinos Barsakis; Milena Ivanova; Susan Hsu; Jonathan Barone; Rhonda Holdsworth; Mary Diviney; Medhat Askar; Amanda Willis; Dawn Railton; Sophie Laflin; Ketevan Gendzekhadze; Arisa Oki; Nicoletta Sacchi; Michela Mazzocco; Marco Andreani; Reem Ameen; Catherine Stavropoulos-Giokas; Amalia Dinou; Margareth Torres; Rodrigo Dos Santos Francisco; Carles Serra-Pages; Damian Goodridge; Sandra Balladares; Maria P Bettinotti; Brian Iglehart; Zahra Kashi; Russell Martin; Chee Loong Saw; Jiannis Ragoussis; Jonathan Downing; Cristina Navarrete; Winnie Chong; Katsuyuki Saito; Martin Petrek; Stana Tokic; Karin Padros; Ma Beatriz Rodriguez; Viktoria Zakharova; Olga Shragina; Susana R Marino; Nicholas K Brown; Takashi Shiina; Shingo Suzuki; Eric Spierings; Qiuheng Zhang; Yuxin Yin; Gerald P Morris; Ana Hernandez; Phillip Ruiz; Seik-Soon Khor; Katsushi Tokunaga; Aviva Geretz; Rasmi Thomas; Fumiko Yamamoto; Kalyan C Mallempati; Sridevi Gangavarapu; Uma Kanga; Shweta Tyagi; Steven G E Marsh; Will P Bultitude; Xiangjun Liu; Dajiang Cao; Maarten Penning; Carolyn K Hurley; Anne Cesbron; Claudia Mueller; Joannis Mytilineos; Eric T Weimer; Mats Bengtsson; Gottfried Fischer; John A Hansen; Chia-Jung Chang; Steven J Mack; Lisa E Creary; Marcelo A Fernandez-Viña
Journal: Hum Immunol Date: 2019-02-06 Impact factor: 2.850

Human leukocyte antigen (HLA) typing by DNA sequencing.

1. HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial.

Review 2. Therapeutic cancer vaccines.

3. HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotype.

4. Validation of Single Nucleotide Variant Assays for Human Leukocyte Antigen Haplotypes HLA-B15:02* and HLA-A31:01* Across Diverse Ancestral Backgrounds.

5. HLA Haplotype Validator for quality assessments of HLA typing.

Review 6. Quality control project of NGS HLA genotyping for the 17th International HLA and Immunogenetics Workshop.

7. Association of HLA-B^∗38:02 with Antithyroid Drug-Induced Agranulocytosis in Kinh Vietnamese Patients.

8. High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual tagging.

9. High-sensitivity HLA typing by Saturated Tiling Capture Sequencing (STC-Seq).

Review 10. Computational Prediction and Validation of Tumor-Associated Neoantigens.